Rehospitalization rates, costs, and risk factors for inflammatory bowel disease: a 16-year nationwide study.

Authors:
Santiago M; Magro F; Correia L; Portela F; Ministro P and 3 more

Journal:
Therap Adv Gastroenterol

Publication Year: 2020

DOI:
10.1177/1756284820923836

PMCID:
PMC8832310

PMID:
35154386

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Therap Adv Gastroenterol

Detailed journal information not available.

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

2/6

0.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Conflict of interest statement: FM has received speaker fees from: AbbVie, Ferring, Falk, Hospira, PharmaKern, MSD, Schering, Lab. Vitoria, Vifor Pharma, OM Pharma. All other authors: none to declare."

Funding Disclosure

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: support was given by the Project “NORTE-01-0145-FEDER-000016” (NanoSTIMA), financed by the North Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, and through the European Regional Development Fund (ERDF). MS acknowledges “Fundação para a Ciência e Tecnologia (FCT)”, Portugal under grant number PD/BD/142890/2018."

Protocol Registration

Open Access

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025